A large retrospective claims analysis found that real-world treatment practices for bipolar I disorder (BP-1) may often diverge from evidence-based guidelines, with antidepressants and benzodiazepines frequently prescribed despite guidelines advising against their use as first-line therapy.
Links to sites outside of NP Psych Navigator are provided as a resource to the viewer. AbbVie Inc accepts no responsibility for the content of non-AbbVie linked sites.